Cloning of cytochrome P-450 2C9 cDNA from human liver and its expression in CHL cells
Author(s) -
Zhu Ge-jian,
Yingnian Yu,
Xin Li,
Yuli Qian
Publication year - 2002
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v8.i2.318
Subject(s) - tolbutamide , complementary dna , microbiology and biotechnology , biology , biochemistry , expression vector , enzyme , molecular cloning , cyp2c9 , cdna library , recombinant dna , cytochrome p450 , affinity chromatography , gene , diabetes mellitus , endocrinology
Using bacterial, yeast, or mammalian cell expressing a human drug metabolism enzyme would seem good way to study drug metabolism-related problems. Human cytochrome P-450 2C9(CYP2C9) is a polymorphic enzyme responsible for the metabolism of a large number of clinically important drugs. It ranks among the most important drug metabolizing enzymes in humans. In order to provide a sufficient amount of the enzyme for drug metabolic research, the CYP2C9 cDNA was cloned and expressed stably in CHL cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom